THE OPPORTUNITY

Vir Biotechnology is looking for an experienced Senior Director, Investor Relations, to join our team. Reporting to the Chief Financial Officer, you will set the strategic direction for the Investor Relations function and play a pivotal role in championing the story of our science, pipeline, and impact to the investment community.

In this key leadership position, you will collaborate across research, development, executive leadership, and corporate communications to translate complex scientific, clinical, business and financial information into compelling, impactful narratives. As the primary contact for investors, analysts, and other key external stakeholders, you will drive the development of strategic communications and provide actionable insights that shape Vir Bio’s external reputation and support our continued growth.

This role is located in our San Francisco headquarters with an expectation of at least 3 days per week in office.

WHAT YOU'LL DO

• Develop and execute an annual investor relations strategy that effectively communicates Vir Bio’s short and long-term vision, corporate goals, and scientific progress to the investment community
• Continuously monitor internal developments, external market events, and shareholder trends for Vir Bio and its peers to inform and adapt investor relations strategy, ensuring messaging and targeting remain relevant and impactful
• Analyze shareholder base and investment trends for Vir Bio and its peers to inform investor targeting strategy, monitor its effectiveness, and identify proactive opportunities to engage with the investment community
• Partner with executive leadership and cross-functional teams to ensure consistency and alignment of messaging and disclosure across all investor materials and presentations
• Lead investor engagement activities, including organizing banking conferences, non-deal roadshows, R&D and analyst days, bus tours, and one-on-one meetings with the investment community, along with research or clinical investor events
• Partner with the CFO as the main point of contact for sell-side analysts, actively engaging to convey Vir Bio’s strategy and key messages. Collect and assess sell-side models, compare them to internal forecasts, and use these insights to inform analyst and investor communications
• Lead investor communications, including corporate presentation decks, management Q&As, website content, the business section of Form 10-K, and other matters as required
• Prepare earnings releases and investor conference call scripts and coach leaders for effective delivery
• Contribute to Board materials, other company press releases, and SEC documents (e.g., Form 8- Ks, Form S-3 fillings)
• Create briefing materials for management in preparation for investor meetings
• Collaborate with cross-functional partners—including Competitive Intelligence, legal, and corporate communications—to monitor industry trends, ensure regulatory compliance, deliver key events like the annual stockholder meeting, and maintain accurate, consistent messaging across all external communications

WHO YOU ARE AND WHAT YOU BRING

• BA/BS required, MBA, M.D., or relevant Ph.D. preferred
• Minimum 10 years of investor relations experience in a publicly traded biotech or pharmaceutical company, at an investor relations firm working with biotech or pharmaceutical clients, or on the buy or sell-side working in biotech or pharmaceuticals
• Ability to present and respond to questions regarding complex scientific and clinical data
• Deep understanding of capital markets, financial statements and valuation models used by investors and analysts
• Well versed in SEC and FDA regulations impacting investor and other external communications
• Exceptional communication abilities, strong financial acumen (including valuation and financial modeling), and a strategic mindset
• Highly collaborative working style across internal and external teams
• Strong network and relationships with influencers in the scientific and healthcare community
• Highly organized and structured, able to manage and guide complex investor communication events, often with multiple competing priorities